Ceará Confirms Third Mpox Case in 2026: Symptoms & Transmission

Health officials in the Brazilian state of Ceará have confirmed a third case of mpox (monkeypox) in 2026, according to data registered on the Integra SUS platform this Friday, March 20th. The primary mode of transmission remains direct person-to-person contact – through skin contact or bodily fluids – and prolonged close exposure to respiratory droplets.

As of today, Ceará has reported a total of 29 mpox notifications this year, with three confirmed cases, 24 discounted, and two still under investigation. This follows a pattern of fluctuating case numbers in recent years: 13 confirmed cases in 2025 and 24 in 2024. While the current number of notifications is lower than in 2025, the confirmation of new cases prompts continued vigilance.

The first confirmed case of 2026, identified on March 10th, involved a 37-year-old white male with a high school education who received medical care and experienced a favorable clinical outcome. This detail, reported by Diário do Nordeste, offers a limited demographic snapshot of the cases seen so far.

Transmission and Diagnosis

Mpox is primarily spread through direct contact with skin lesions and bodily fluids of an infected person. Transmission can also occur through close and prolonged exposure to respiratory droplets. The diagnostic process involves laboratory testing – either molecular testing or genetic sequencing – utilizing samples collected from skin lesions. Samples are sent to reference laboratories across Brazil for analysis, with preference given to collecting material from active lesions, or crusts from healed ones.

The emergence of new cases in Ceará aligns with a broader national trend. The Brazilian Ministry of Health’s National Center for Epidemiological Intelligence and Genomic Surveillance reports 140 confirmed cases of mpox across the country in 2026, alongside 539 suspected cases. This suggests ongoing, albeit contained, circulation of the virus within Brazil.

Recent global developments also contribute to the need for continued monitoring. In October 2025, health officials in Southern California identified three cases of a new mpox strain, known as clade I, genetically distinct from the strain that caused the 2022 outbreak. These cases were not linked to international travel, indicating potential community transmission. While the severity of clade I is still under investigation, initial reports suggest it may be more serious than previous strains, prompting concern among public health officials.

The Ceará State Health Department (Sesa) continues to monitor the epidemiological situation and maintain guidance on surveillance and prevention. Individuals suspecting mpox infection are advised to seek medical attention at a Basic Health Unit (UBS) or an Urgent Care Unit (UPA) for diagnostic testing and potential treatment. More severe cases are referred to the São José Hospital (HSJ), the state’s reference center for mpox treatment.

As mpox continues to circulate both globally and within Brazil, ongoing surveillance, rapid diagnosis, and public health education remain crucial to mitigating its spread and protecting vulnerable populations. The confirmation of these cases in Ceará underscores the importance of continued vigilance and adherence to preventative measures.